pRb2/p130 has an anti-apoptotic effect on apoptosis triggered by camptothecin and doxorubicin, and not by taxol / Tonini, T; Gabellini, C; Bagella, Luigi Marco; D'Andrilli, G; Romano, G; Masciullo, V; Scambia, G; Zupi, G; Giordano, A.. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - 10 (23):(2004), pp. 8085-8093.

pRb2/p130 has an anti-apoptotic effect on apoptosis triggered by camptothecin and doxorubicin, and not by taxol

BAGELLA, Luigi Marco;
2004-01-01

2004
pRb2/p130 has an anti-apoptotic effect on apoptosis triggered by camptothecin and doxorubicin, and not by taxol / Tonini, T; Gabellini, C; Bagella, Luigi Marco; D'Andrilli, G; Romano, G; Masciullo, V; Scambia, G; Zupi, G; Giordano, A.. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - 10 (23):(2004), pp. 8085-8093.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/57727
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 12
social impact